MY ACCOUNT | NEWSLETTER |

Electrocardiographic findings in dogs with SIRS diagnosis


Several studies performed in humans have demonstrated that the onset of systemic inflammatory response syndrome (SIRS) represents a high-risk condition that could lead to myocardial damage and arrhythmias. The authors of this study also hypothesized cardiac involvement for dogs affected by SIRS. 

To assess this hypothesis, the team enrolled 24 dogs with a diagnosis of SIRS (13 intact males, seven females and four spayed females) with an age ranging from 4 to 11 years and an average weight of 24 kg. 

The dogs were divided into two groups according to their prognosis: Survivors (G1) and non-survivors (G2), composed of 13 and 11 dogs, respectively. Researchers also enrolled healthy dogs in the study as the control group. All dogs with a history of cardiac or renal disease were excluded. At the inclusion, each patient underwent a physical examination and a complete cell count. The team performed a biochemistry panel (including electrolyte profile). The blood cardiac Troponin I (cTnI) was measured. For each clinical variable indicative of SIRS, a score between 0 (absence) and 1 (presence) was applied. In addition, the team recorded an electrocardiographic examination. 

Based on the findings, 17 of 24 or 71% of the dogs with SIRS showed arrhythmias, of which n. 6 belonged to the G1, while n. 11 belonged to the G2. 

Most represented findings were sinus tachycardia, followed by monomorphic premature ventricular beats. Less common were first-degree atrioventricular block and sinus bradycardia. 

Notably, in G1 dogs, only sinus tachycardia and premature ventricular beats were observed by the team. G2 dogs presented total and banded leukocytes significantly higher than those of G1. The clinical score suggestive of SIRS was significantly higher in G2 than in G1 dogs. Moreover, a significantly higher value of cTnI was observed in the G2 group compared to the G1 group. 

The researchers concluded that data suggested cardiac involvement in dogs with SIRS, analogously to humans, that may significantly influence the patient's prognosis.

Michela Pugliese et al. “Electrocardiographic Findings and Cardiac Troponin I Assay in Dogs with SIRS Diagnosis.” Vet Sci. 24 November 2022. 9(12):655. doi: 10.3390/vetsci9120655.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Advancing the 3Rs: innovation, implementation, ethics and society

Like0
Dislike0

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Like0
Dislike0

Does Lung Function Imaging Modality Have a Dosimetric Impact On Functional Avoidance Treatment Planning: Assessment Using Prospective Clinical Trial Data

Like0
Dislike0

One Committed and Caring NC State Veterinary Student, So Many Choices

Like1
Dislike0

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top